Evidence map›Paper›PMID 21284985›Full record

ArticleCell metabolism2011

Brain insulin controls adipose tissue lipolysis and lipogenesis.

Thomas Scherer, James O'Hare, Kelly Diggs-Andrews, Martina Schweiger, Bob Cheng, Claudia Lindtner, Elizabeth Zielinski, Prashant Vempati, Kai Su, Shveta Dighe and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 136 papers.

0numbers the graph read from it
0cells of the map it votes in
136citing papers in PubMed
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

136 citing papers in PubMed, 252 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Brain Nutrient Sensing: A Unifying Framework.Annual review of physiology · 2026
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Why do some individuals with obesity remain metabolically healthy?Trends in endocrinology and metabolism: TEM · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. The Metabolic Syndrome, a Human Disease.International journal of molecular sciences · 2024
    Review
  18. Review
  19. Article
  20. Review

76 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 3 countries.

Thomas SchererDepartment of Medicine, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1055, New York, NY 10029-6574, USA.
James O'Hare
Kelly Diggs-Andrews
Martina Schweiger
Bob Cheng
Claudia Lindtner
Elizabeth Zielinski
Prashant Vempati
Kai Su
Shveta Dighe
Thomas Milsom
Michelle Puchowicz
Ludger Scheja
Rudolf Zechner
Simon J Fisher
Stephen F Previs
Christoph Buettner
Icahn School of Medicine at Mount Sinai · USCase Western Reserve University · USUniversity of Graz · ATWashington University in St. Louis · USUniversität Hamburg · DE

Funding

YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
Coordinating and Bioinformatics Unit for the MMPC/DiaCompU24DK076169 · NIDDK · AUGUSTA UNIVERSITY · PI MCINDOE, RICHARD A. · 2006 to 2018
$42.4M
Regulation of Adipose Tissue Metabolism by Central Insulin and LeptinR01DK083658 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BUETTNER, CHRISTOPH · 2009 to 2013
$1.9M
Hypothalmic glucose sensing and hypoglycemic counterregulationR01DK073683 · NIDDK · WASHINGTON UNIVERSITY · PI FISHER, SIMON J · 2007 to 2011
$1.5M
The role of Stat3 signaling in leptin's pleitropic action.K08DK074873 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BUETTNER, CHRISTOPH · 2006 to 2009
$510k
The role of the endocannabinoid system in regulating hepatic glucose fluxesR03DK082724 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BUETTNER, CHRISTOPH · 2009 to 2010
$169k
NCRR NIH HHS UL1 RR024139NIDDK NIH HHS DK073683NIDDK NIH HHS DK074873NIDDK NIH HHS DK082724NIDDK NIH HHS DK083568NIDDK NIH HHS K08 DK074873NIDDK NIH HHS R01 DK073683NIDDK NIH HHS R01 DK083658NIDDK NIH HHS R03 DK082724NIDDK NIH HHS U24 DK076169
6 · The paper itself

Abstract

White adipose tissue (WAT) dysfunction plays a key role in the pathogenesis of type 2 diabetes (DM2). Unrestrained WAT lipolysis results in increased fatty acid release, leading to insulin resistance and lipotoxicity, while impaired de novo lipogenesis in WAT decreases the synthesis of insulin-sensitizing fatty acid species like palmitoleate. Here, we show that insulin infused into the mediobasal hypothalamus (MBH) of Sprague-Dawley rats increases WAT lipogenic protein expression, inactivates hormone-sensitive lipase (Hsl), and suppresses lipolysis. Conversely, mice that lack the neuronal insulin receptor exhibit unrestrained lipolysis and decreased de novo lipogenesis in WAT. Thus, brain and, in particular, hypothalamic insulin action play a pivotal role in WAT functionality.

Indexed as

Adipose Tissue, WhiteAnimalsBrainGlucoseInsulinLipogenesisLipolysisMaleMiceRatsRats, Sprague-DawleyReceptor, InsulinSignal TransductionGlucoseInsulinReceptor, Insulin

Identifiers

PMID21284985
PMCPMC3061443
OpenAlexW2044013713

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.